+Vote!
PR News Wire (Free subscription) | 1 hour ago
EVANSTON, Ill. and Exton, Pa., Oct. 12 /PRNewswire/ -- Mentice, Inc., a
leading developer and supplier of virtual reality (VR) based medical
simulation systems and Education Management Solutions, Inc. (EMS), a leader
in clinical skills training and evaluation software solutions, today
announced at the Transcatheter Cardiovascular Therapeutics symposium in
Washington D.C., an OEM partnership that enables...
+Vote!
Bioethics.net (Free subscription) | yesterday
Pharmaceutical giants face a conundrum, as illustrated by two recent events. Eli Lilly ( LLY ) agreed to pay $6.5 billion in cash for ImClone Systems ( IMCL ) to get its hands on a roster of experimental cancer drugs. And Roche, bowing to pressure from Britain's National Institute for Health & Clinical Excellence, slashed the price of lung cancer drug Tarceva by $1,200 to $10,830 per four-month course...
1Vote!
Newswise (Free subscription) | yesterday
MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2008 National Conference & Exhibition that add to the company's growing body of research into the prevention of respiratory syncytial virus (RSV), a leading cause of viral respiratory infection among preterm infants.
+Vote!
Patent Docs (Free subscription) | yesterday
By Kevin E. Noonan -- The Federal Circuit today issued an Order, pursuant to Federal Rule of Appellate Procedure 36, affirming the District Court's grant of a preliminary injunction in Amgen Inc. v. F. Hoffmann-La Roche Ltd., Amgen's patent infringement suit over Roche's Mircera® drug product. The District Court, having granted the preliminary injunction on February 28, 2008, after a jury verdict that...
+Vote!
PR News Wire (Free subscription) | yesterday
WASHINGTON and MENLO PARK, Calif., Oct. 10 /PRNewswire-FirstCall/ --
XTENT, Inc. (Nasdaq: ) today announced that it plans to present
long-term follow-up data from the CUSTOM I, II and III clinical trials next
week at the Cardiovascular Research Foundation's (CRF) twentieth annual
Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, DC.
The CUSTOM clinical trials are prospective studies...
+Vote!
The San Francisco Business Times (Free subscription) | 10/10/2008
PDL BioPharma Inc. named two biotech and medical device veterans to its board, giving them baseline $35,000 annual cash retainers, temporary $10,000 monthly cash retainers and options to buy thousands of shares. (ANSV) (DNA) (BSX) (PDLI)
1Vote!
Business Wire (Free subscription) | 10/10/2008
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Today the United States (U.S.) Court of Appeals for the Federal Circuit issued a ruling that affirms the preliminary injunction ordered by the U.S.
+Vote!
Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies (Free subscription) | 10/10/2008
REDWOOD CITY, CA (MARKET WIRE) PDL BioPharma, Inc. (NASDAQ: PDLI) today announced the election of Paul W. Sandman and John P. McLaughlin to the company's board of directors.
+Vote!
PR News Wire (Free subscription) | 10/10/2008
EMERYVILLE, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Neurobiological
Technologies, Inc. (NTI(R)) (Nasdaq: ), today announced it will hold a
conference call on Monday, October 13, to provide an update on the
Viprinex(TM) (ancrod) Phase 3 Trial Program for acute ischemic stroke.
Hosting the call will be Paul E. Freiman, president and chief executive
officer and Warren W. Wasiewski, chief medical officer.
...
+Vote!
The Baltimore Business Journal (Free subscription) | 10/10/2008
In sizing up the credit crisis and the impact it has had and will have on the biotechnology industry, David Mott voiced a sliver of good hope. His message: It has happened before.
+Vote!
PR News Wire (Free subscription) | 10/10/2008
Leading researchers in academia and industry reveal powerful effects of
recombinant lactoferrin (tradename: Lacromin) in mammalian cell culture
leading to a significant boost in productivity.
FORT COLLINS, Colo., Oct. 10 /PRNewswire/ -- A recently published study
in the scientific journal In Vitro Cellular & Developmental Biology
revealed that recombinant lactoferrin (tradename: Lacromin, see
)...
2Vote!
Fiercebiotech (Free subscription) | 10/10/2008
Science announced the results of its annual Top Employers survey. After placing second last year, Genentech once again claimed the top spot for the sixth year. Missouri-based Monsanto climbed six spots to come in at number two this year, with Genzyme rounding out the top three. The annual web-based survey, now in its seventh year, polls employees of biotech, biopharma and pharmaceutical companies,...
1Vote!
Red Orbit (Free subscription) | 10/10/2008
Synageva BioPharma announced today the appointment of Mark Goldberg, M.D., Senior Vice President of Clinical Research at Genzyme Corp., and a leading medical oncologist and hematologist, to the Company's Board of Directors.
